Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rosanna, Pessolano"'
Autor:
Franca Fagioli, Francesca Carraro, Massimo Berger, Manuela Spadea, M. Barone, Francesco Saglio, Paola Quarello, Rosanna Pessolano, E. Vassallo
Publikováno v:
Bone Marrow Transplantation. 56:586-595
T-cell replete hematopoietic stem cell transplantation (HSCT) from a haploidentical donor followed by high doses of cyclophosphamide has been demonstrated to provide the best chances of a cure for many children in need of an allograft but who lack bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c73dd22a46def8829ebfe03dcf4c7c
https://doi.org/10.1038/s41409-020-01063-2
https://doi.org/10.1038/s41409-020-01063-2
Autor:
Massimo Berger, Marta Barone, Manuela Spadea, Francesco Saglio, Rosanna Pessolano, Franca Fagioli
Publikováno v:
Pediatric transplantationREFERENCES. 26(4)
Allogeneic hematopoietic stem cell transplantation (HSCT) from an unrelated HLA-mismatched donor (MMUD) is one of the alternatives where an HLA-matched donor is not found. The aim of this study was to compare bone marrow (BM) versus peripheral blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b762e2926ae9b878e1bd0245f2e8c9a
https://pubmed.ncbi.nlm.nih.gov/35092128
https://pubmed.ncbi.nlm.nih.gov/35092128
Autor:
E. Vassallo, Franca Fagioli, Rosanna Pessolano, Massimo Berger, Francesco Saglio, Francesca Carraro
Publikováno v:
Journal of Pediatric Hematology/Oncology. 41:e506-e509
Prognosis of relapsed leukemia patients after second allogeneic hematopoietic stem cell transplantation (HSCT2) is historically considered very poor. We report the outcome of 18 pediatric patients after failure of HSCT2. The 2-year overall survival w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac5d7e1bae0ad745ef19e6f942ded35
https://doi.org/10.1097/mph.0000000000001507
https://doi.org/10.1097/mph.0000000000001507
Autor:
Manuela Spadea, Sergio Grassitelli, Rosanna Pessolano, Franca Fagioli, Massimo Berger, Carlo Scolfaro, Francesco Saglio, E. Vassallo, Francesca Carraro
Publikováno v:
Transplant Infectious Disease
So far, we do not have any published database regarding HCT patients during the present pandemic. We herein describe the first case of COVID-19 presenting in the early hematopoietic cell transplantation (HCT) setting.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232a570304412b812fb7442cd6bc415f
http://hdl.handle.net/2318/1757307
http://hdl.handle.net/2318/1757307
Autor:
Massimo Aglietta, Franca Fagioli, Paolo Nicoli, Daniela Cilloni, Massimo Berger, Daniela Caravelli, Fabrizio Carnevale-Schianca, E. Vassallo, Marco De Gobbi, Marta Barone, Luca Paruzzo, Rosanna Pessolano
Publikováno v:
SSRN Electronic Journal.
Allogeneic hematopoietic stem cell transplantation (HSCT) from an unrelated HLA-mismatched donor (MMUD) is one of the alternatives where an HLA-matched donor is not found. Patients were divided into 4 groups: 43 pediatric with ATG and bone marrow as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8eca463bfdc1b46f7c075530f4212bc8
https://doi.org/10.2139/ssrn.3717833
https://doi.org/10.2139/ssrn.3717833
Autor:
E. Vassallo, Massimo Berger, Francesca Carraro, Franca Fagioli, Francesco Saglio, Rosanna Pessolano
Publikováno v:
Pediatric transplantationREFERENCES. 24(7)
aGvHD remains a major obstacle to successful HSCT. We report our experience on steroid-refractory aGvHD III and IV from 1989 to 2017. Ninety patients with aGvHD III or IV were stratified according to the HSCT year: 1989-1998, 1999-2007, and 2008-2017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92919991bb0e68c5f2648dbdb2e7aae0
https://pubmed.ncbi.nlm.nih.gov/32844519
https://pubmed.ncbi.nlm.nih.gov/32844519
Autor:
Dario Sangiolo, Ivana Ferrero, Daniela Gottardi, Andrea Saglietto, Luca Paruzzo, Franca Fagioli, E. Vassallo, Alessandro Cignetti, Valentina Gaidano, Loretta Gammaitoni, Daniela Caravelli, Lorenzo D'Ambrosio, Stefano Poletto, Delia Rota-Scalabrini, Alessandra Polo, Massimo Aglietta, Massimo Berger, Susanna Gallo, Rosanna Pessolano, Francesco Saglio, Paolo Becco, Pio Manlio Mirko Frascione, Fabrizio Carnevale-Schianca, Marco Fizzotti, Monica Mangioni, Giovanni Grignani, Milena Salierno
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 6
Journal of Clinical Medicine, Vol 10, Iss 1173, p 1173 (2021)
Volume 10
Issue 6
Journal of Clinical Medicine, Vol 10, Iss 1173, p 1173 (2021)
Combined direct antineoplastic activity and the long-lasting immunological effects of allogeneic hematopoietic cell transplant (HCT) can cure many hematological malignancies, but broad adoption requires non-relapse mortality (NRM) rates and graft-ver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba79ee87719be0b7bdce684ac64491b6
https://doi.org/10.3390/jcm10061173
https://doi.org/10.3390/jcm10061173
Autor:
Rosanna Pessolano, Alessandro Jenkner, C De Lurentis, L. De Sio, Raffaele Cozza, M. De Ioris, Giuseppe Milano, P. Fidani, Ilaria Ilari
Publikováno v:
Bone Marrow Transplantation. 45:1274-1280
We report the toxicity of high-dose chemotherapy (HDC) based on etoposide, thiotepa and CY (ETC) in children with poor-prognosis Ewing's sarcoma family tumors (ESFTs). A total of 26 patients with high-risk ESFT (metastasis or axis localization or tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d126248266bd6721612d7716f65a5c5
https://doi.org/10.1038/bmt.2009.353
https://doi.org/10.1038/bmt.2009.353
Autor:
Maria Antonietta, DE Ioris, Benedetta, Contoli, Alessandro, Jenkner, Maria Debora, DE Pasquale, Annalisa, Serra, Luigi, DE Sio, Rosanna, Pessolano, Maria Carmen, Garganese, Alessandro, Crocoli, Teresa, Corneli, Renata, Boldrini, Aurora, Castellano
Publikováno v:
Anticancer research. 32(12)
Although high-dose chemotherapy (HDC) represents the standard of treatment for high-risk neuroblastoma (NBL), the most effective conditioning regimen still remains to be identified.Forty-one high-risk NBL entered into local protocol based on inductio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e1db0821b006fc3e815461df6881fa3
https://pubmed.ncbi.nlm.nih.gov/23225462
https://pubmed.ncbi.nlm.nih.gov/23225462